General Hospital Medicine   

For example, do you consider "cautious" IV fluids or otherwise consider early vasopressors?

For example, do you routinely supplement with calcium carbonate, magnesium hydroxide, aluminum hydroxide, simethicone, sucralfate, etc.?

Assume QTc is not prolonged, electrolytes are reasonably normal, and the patient is not already on heavy psychotropic polypharmacy.

Do you use the traditional strict limit of 1.5 L, or do you consider removing more volume if a patient appears to tolerate it?

For example, would you consider alternatives to paracentesis (Denver shunt placement, CART therapy, or permanent tunneled catheters) that might better...

For example, do you find trending WBC, procalcitonin, CRP, etc., more or less helpful?

For example, do you think the benefits of sequential compression devices outweigh the risk of falls, delirium, etc.?

In particular, how do you reconcile situations where lung POCUS findings contradict other components of volume assessment (e.g. JVD, peripheral edema,...

O'Toole et al., PMID 36652352

Should we consider this as a unique point during goal of care discussions, separate from code status, comfort measures only, etc.?

Do you extend the course of fidaxomicin past initial 10 days to at least 3-7 days after completion of antibiotics?